Resonance Health Limited (ASX:RHT)

Resonance Health Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 20, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	18	26	19	26	71	67
Market Cap Growth	-14.68%	36.13%	-25.00%	-63.87%	7.38%	50.05%
Enterprise Value	18	21	13	18	63	63
Last Close Price	0.04	0.06	0.04	0.06	0.15	0.15
PE Ratio	-	155.74	-	-	122.01	-
PS Ratio	1.70	3.07	4.40	6.70	18.92	18.15
PB Ratio	1.79	2.41	1.95	2.42	6.04	6.72
P/TBV Ratio	6.15	7.18	1.95	2.42	6.04	6.72
P/FCF Ratio	7.45	22.77	-	-	63.34	50.87
P/OCF Ratio	7.08	19.01	-	-	60.96	50.78
EV/Sales Ratio	1.71	2.42	2.99	4.75	16.79	17.26
EV/EBITDA Ratio	-	-	-	-	151.50	-
EV/EBIT Ratio	-	-	-	-	158.72	-
EV/FCF Ratio	7.48	17.95	-	-	56.23	48.39
Debt / Equity Ratio	0.36	0.34	0.03	0.03	0.01	0.01
Debt / EBITDA Ratio	-	-	-	-	0.13	-
Debt / FCF Ratio	1.50	3.19	-	-	0.05	0.09
Asset Turnover	0.73	0.55	0.39	0.32	0.33	0.43
Quick Ratio	1.40	1.49	8.57	9.76	15.77	14.58
Current Ratio	1.46	1.51	8.63	10.34	15.84	14.65
Return on Equity (ROE)	-3.11%	1.62%	-7.57%	-10.14%	5.39%	-9.05%
Return on Assets (ROA)	-5.58%	-2.30%	-7.50%	-7.90%	2.18%	-7.12%
Return on Capital (ROIC)	-6.76%	-2.90%	-8.03%	-8.34%	2.28%	-7.57%
Return on Capital Employed (ROCE)	-	-	-	-	3.40%	-
Earnings Yield	-1.73%	0.64%	-4.03%	-4.42%	0.82%	-1.07%
FCF Yield	13.43%	4.39%	-2.30%	-6.10%	1.58%	1.97%
Buyback Yield / Dilution	-1.66%	-1.59%	-	-1.97%	-4.59%	-6.52%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.